Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2025 05:00 ET | Source: Yaqrit

Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments

Yaqrit strengthens leadership team with leading biostatistician, an expert in liver trial design, and renowned US econ/finance strategist joining Board
May 07, 2025 02:30 ET | Source: Yaqrit

Yaqrit’s HE candidates set for phase 3 as company shows underpinning data at EASL

Yaqrit presents phase 2a data at EASL on oral HE prevention treatment; and an improved HE patient staging tool approved for use by FDA in HE phase 3
April 28, 2025 11:27 ET | Source: Yaqrit

Yaqrit showcases clinical progress at the European Association for the Study of the Liver (EASL) Congress, May 7-10th

Yaqrit announces eight upcoming presentations at the EASL Congress showcasing progress for drugs and devices in late stage trials in advanced liver disease
March 21, 2025 06:00 ET | Source: Yaqrit

Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure

NIHR grant funds pivotal trial for Yaqrit's liver support device, DIALIVE, with potential to resolve life-threatening condition and impact survival.